At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
00853 MICROPORT
Trading 04-29 10:56:15
6.400
+0.500
+8.47%
High6.520Low5.990Vol8.89M
Open6.000D1 Closing5.900Amplitude8.98%
Mkt Cap11.74BTradable Cap11.74BTotal Shares1.83B
T/O55.99MT/O Rate0.48%Tradable Shares1.83B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BRIEF-Microport Scientific Entered Convertible Facility Agreement
Reuters  ·  04-05
BRIEF-Microport Scientific Entered Convertible Facility Agreement
BRIEF-Microport Scientific Sees Losses To Not Greater Than USD650 Million For Year
Reuters  ·  03-22
BRIEF-Microport Scientific Sees Losses To Not Greater Than USD650 Million For Year
BRIEF-Microport Scientific Sees Losses Of Not Greater Than $580 Million For Year
Reuters  ·  03-05
BRIEF-Microport Scientific Sees Losses Of Not Greater Than $580 Million For Year
Even after rising 9.8% this past week, MicroPort Scientific (HKG:853) shareholders are still down 83% over the past three years
Simply Wall St.  ·  02-26
Even after rising 9.8% this past week, MicroPort Scientific (HKG:853) shareholders are still down 83% over the past three years
MicroPort Scientific Corporation's (HKG:853) largest shareholders are private companies who were rewarded as market cap surged HK$550m last week
Simply Wall St.  ·  01-30
MicroPort Scientific Corporation's (HKG:853) largest shareholders are private companies who were rewarded as market cap surged HK$550m last week
BRIEF-Microport Scientific Says Shanghai Microport Endovascular Medtech Sees Increase In FY Profit
Reuters  ·  01-29
BRIEF-Microport Scientific Says Shanghai Microport Endovascular Medtech Sees Increase In FY Profit
BRIEF-Microport Scientific Completes Issue Of $220 Mln 5.75% Convertible Bonds Due 2028
Reuters  ·  2023-12-20
BRIEF-Microport Scientific Completes Issue Of $220 Mln 5.75% Convertible Bonds Due 2028
BRIEF-Microport Scientific Says Proposed Issue Of A Shares By Shanghai Microport Endovascular Medtech (Group)
Reuters  ·  2023-12-14
BRIEF-Microport Scientific Says Proposed Issue Of A Shares By Shanghai Microport Endovascular Medtech (Group)
MicroPort Scientific Corporation (HKG:853) Shares Could Be 42% Below Their Intrinsic Value Estimate
Simply Wall St.  ·  2023-12-11
MicroPort Scientific Corporation (HKG:853) Shares Could Be 42% Below Their Intrinsic Value Estimate
BRIEF-Microport Scientific Updates On Significant Fluctuation On Share Price Recently
Reuters  ·  2023-12-11
BRIEF-Microport Scientific Updates On Significant Fluctuation On Share Price Recently
MicroPort Scientific Shares Fall 25% on Convertible Bond Plan
Dow Jones  ·  2023-12-06
MicroPort Scientific Shares Fall 25% on Convertible Bond Plan
BUZZ-MicroPort hits near 4-year low on plan to issue convertible bonds
Reuters  ·  2023-12-06
BUZZ-MicroPort hits near 4-year low on plan to issue convertible bonds
BRIEF-Microport Scientific Announces Repurchase Of US$700 Mln Zero Coupon Convertible Bonds
Reuters  ·  2023-12-05
BRIEF-Microport Scientific Announces Repurchase Of US$700 Mln Zero Coupon Convertible Bonds
MicroPort Scientific (HKG:853) adds HK$2.8b to market cap in the past 7 days, though investors from three years ago are still down 57%
Simply Wall St.  ·  2023-11-05
MicroPort Scientific (HKG:853) adds HK$2.8b to market cap in the past 7 days, though investors from three years ago are still down 57%

Introduction

Company Name.
MICROPORT
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.
Issue price:
--